Suggestions for regulatory agency approval of second-line systemic therapy for metastatic transitional cell carcinoma. uri icon

Overview

publication date

  • February 16, 2010

Research

keywords

  • Antineoplastic Agents, Phytogenic
  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Transitional Cell
  • Drug Approval
  • Urologic Neoplasms
  • Vinblastine

Identity

Scopus Document Identifier

  • 77952303284

Digital Object Identifier (DOI)

  • 10.1200/JCO.2009.27.1114

PubMed ID

  • 20159797

Additional Document Info

volume

  • 28

issue

  • 13